Hennion & Walsh Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Buy
28,669
+1,452
+5% +$117K 0.06% 355
2026
Q1
$2.36M Buy
27,217
+3,636
+15% +$348K 0.08% 308
2025
Q4
$2.27M Buy
23,581
+4,592
+24% +$446K 0.08% 324
2025
Q3
$1.81M Buy
18,989
+4,792
+34% +$441K 0.07% 372
2025
Q2
$1.24M Buy
14,197
+6,184
+77% +$524K 0.05% 441
2025
Q1
$720K Buy
8,013
+4,507
+129% +$403K 0.03% 552
2024
Q4
$280K Buy
+3,506
New +$304K 0.01% 771
2022
Q2
Sell
-5,693
Closed -$631K 784
2022
Q1
$631K Buy
5,693
+2,344
+70% +$248K 0.03% 460
2021
Q4
$346K Sell
3,349
-181
-5% -$21K 0.02% 618
2021
Q3
$442K Sell
3,530
-46
-1% -$5.95K 0.02% 533
2021
Q2
$444K Sell
3,576
-33
-0.9% -$4.14K 0.02% 547
2021
Q1
$426K Buy
+3,609
New +$423K 0.03% 524

Other funds holding MDT

Hennion & Walsh Asset Management's MDT Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its Medtronic (MDT) stake by 5.3% in Q2 2026, buying an estimated $117K and bringing the position to 28,669 shares worth $2.24M. The position accounts for 0.06% of the portfolio, ranked #355.

Hennion & Walsh Asset Management first reported a position in MDT in Q1 2021 and has held it in 12 quarters since. The position peaked at $2.36M in Q1 2026. 620 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Hennion & Walsh Asset Management held 28,669 shares of Medtronic worth $2.24M as of Q2 2026.
  • Hennion & Walsh Asset Management bought 1,452 Medtronic shares in Q2 2026, an estimated $117K.
  • Medtronic made up 0.06% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #355 holding.
  • Hennion & Walsh Asset Management first reported a position in Medtronic in Q1 2021 and has held it in 12 quarters since.
  • Hennion & Walsh Asset Management's Medtronic position peaked at $2.36M in Q1 2026.
  • 620 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.